Akari Therapeutics, Plc (NASDAQ: AKTX) today announced that it has priced its previously announced underwritten public offering of 3,480,000 American ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE